Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantifying Facial Feminization Surgery's Impact: Focus on Patient Facial Satisfaction.
Alper DP, Almeida MN, Hu KG, De Baun HM, Hosseini H, Williams MCG, Salib A, Shah J, Persing JA, Alperovich M. Alper DP, et al. Among authors: de baun hm. Plast Reconstr Surg Glob Open. 2023 Nov 3;11(11):e5366. doi: 10.1097/GOX.0000000000005366. eCollection 2023 Nov. Plast Reconstr Surg Glob Open. 2023. PMID: 37928639 Free PMC article.
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.
Sehatpour P, Iosifescu DV, De Baun HM, Shope C, Mayer MR, Gangwisch J, Dias E, Sobeih T, Choo TH, Wall MM, Medalia A, Saperstein AM, Kegeles LS, Girgis RR, Carlson M, Kantrowitz JT. Sehatpour P, et al. Among authors: de baun hm. Biol Psychiatry. 2023 Jul 15;94(2):164-173. doi: 10.1016/j.biopsych.2023.01.015. Epub 2023 Jan 28. Biol Psychiatry. 2023. PMID: 36958998 Free PMC article. Clinical Trial.
Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.
Sehatpour P, Javitt DC, De Baun HM, Carlson M, Beloborodova A, Margolin DH, Carlton MBL, Brice NL, Kantrowitz JT. Sehatpour P, et al. Among authors: de baun hm. Neuropsychopharmacology. 2022 Feb;47(3):711-718. doi: 10.1038/s41386-021-01170-8. Epub 2021 Oct 20. Neuropsychopharmacology. 2022. PMID: 34667294 Free PMC article. Clinical Trial.
Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.
Sehatpour P, Avissar M, Kantrowitz JT, Corcoran CM, De Baun HM, Patel GH, Girgis RR, Brucato G, Lopez-Calderon J, Silipo G, Dias E, Martinez A, Javitt DC. Sehatpour P, et al. Among authors: de baun hm. Front Psychiatry. 2021 Feb 2;11:629144. doi: 10.3389/fpsyt.2020.629144. eCollection 2020. Front Psychiatry. 2021. PMID: 33603682 Free PMC article.
13 results